Inflammatory responses play a critical role in ischemic brain injury. induces the expression of inflammatory cytokines, and acetylbritannilactone (ABL) exerts potent antiinflammatory actions by inhibiting expression of inflammation-related genes. However, the functions of miR-155 and the actual relationship between ABL and miR-155 in ischemia-induced cerebral inflammation remain unclear. In this study, cerebral ischemia of wild-type (WT) and miR-155 -/-mice was induced by permanent middle cerebral artery occlusion (MCAO). pAd-miR-155 was injected into the lateral cerebral ventricle 24 h before MCAO to induce miR-155 overexpression. MCAO mice and oxygen-glucose deprivation (OGD)-treated BV2 cells were used to examine the effects of ABL and miR-155 overexpression or deletion on the expression of proinflammatory cytokines. We demonstrated that ABL treatment significantly reduced neurological deficits and cerebral infarct volume by inhibiting tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) expression in ischemic cerebral tissue and OGD-treated BV2 cells. Mechanistic studies suggested that the observed decrease in TNF-α and IL-1β expression was attributable to the ABL-induced suppression of the expression of nuclear factorkappa B (NF-κB) and Toll-like receptor 4 (TLR4). We further found that miR-155 promoted TNF-α and IL-1β expression by upregulating TLR4 and downregulating the expression of suppressor of cytokine signaling 1 (SOCS1) and myeloid differentiation primary response gene 88 (MyD88), while ABL exerted an inhibitory effect on miR-155-mediated gene expression. In conclusion, miR-155 mediates inflammatory responses in ischemic cerebral tissue by modulating TLR4/MyD88 and SOCS1 expression, and ABL exerts its antiinflammatory action by suppressing miR-155 expression, suggesting a novel miR-155-based therapy for ischemic stroke. scription factors at the transcriptional level but also by microRNAs (miRNAs, miRs) at the posttranscriptional level. Emerging evidence suggest that miRNAs are involved in regulating several aspects of inflammation (10,11) and the response to cerebral ischemia (12). Among various miRNAs, miR-155 is an inflammation-related miRNA. Its expression is induced in inflammatory macrophages (11,13), as well as in the ischemic cerebral cortex by middle cerebral artery occlusion (MCAO) surgery (14) and, in turn, it enhances proinflammatory cytokine expression in macrophages by regulating the NF-κB signaling pathway (11,15). In addition, miR-155 can exert both pro-and antiinflammatory effects by targeting different mediators of inflammatory signaling, such as SHIP1, SOCS1, SMAD2 and TAB2 (16,17). Given the importance of miR-155 in the development of postischemic brain inflammation, understanding the role of miR-155 and the mechanism of miR-155 actions in ischemic cerebral injury will provide novel insights into ischemic stroke therapy. Pharmacological alleviation of inflammatory response is one of the most promising avenues for stroke therapy. Acetylbritannilactone (ABL) is a new antiin...